Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 1 2Phase NA 1Phase 3 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Lymphoma, Follicular 15Lymphoma 15Multiple Myeloma 14Lymphoma, Mantle-Cell 14Leukemia, Myeloid, Acute 14Leukemia, Lymphocytic, Chronic, B-Cell 14Lymphoma, Non-Hodgkin 13Leukemia 13Hodgkin Disease 13Congenital Abnormalities 13Burkitt Lymphoma 13Lymphoma, Large B-Cell, Diffuse 12Lymphoma, B-Cell, Marginal Zone 12Leukemia, Myeloid, Chronic-Phase 12Lymphoma, Large-Cell, Immunoblastic 11Leukemia, Myeloid, Accelerated Phase 11Myeloproliferative Disorders 10Myelodysplastic Syndromes 10Recurrence 9Primary Myelofibrosis 9Lymphoma, T-Cell, Cutaneous 9Dendritic Cell Sarcoma, Interdigitating 9Blast Crisis 8Sezary Syndrome 7Mycosis Fungoides 7Leukemia, Myelomonocytic, Chronic 7Anemia, Refractory, with Excess of Blasts 7Waldenstrom Macroglobulinemia 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Cytarabine 3fludarabine phosphate 1Pravastatin 1Idarubicin 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Drug Therapy 1Drug Screening Assays, Antitumor 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Leukemia, Myelomonocytic, Acute × fludarabine phosphate × Clear all
NCT02105116 2021-08-24

AML Therapy With Irradiated Allogeneic Cells

Rutgers, The State University of New Jersey

Phase NA Terminated
6 enrolled 6 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡